Copyright
©The Author(s) 2017.
World J Gastroenterol. Sep 14, 2017; 23(34): 6294-6305
Published online Sep 14, 2017. doi: 10.3748/wjg.v23.i34.6294
Published online Sep 14, 2017. doi: 10.3748/wjg.v23.i34.6294
No. of patients on biologicals per 100000 population | Availability score | Affordability ratio | GDP per capita | % of public health expenditure in the total health expenditure | % of general government expenditure in public health expenditure | |
No. of patients on biologicals per 100000 population | 1.0000 | - | - | - | - | - |
-0.7497 | 1.0000 | - | - | - | - | |
Availability score | (P = 0.0125) | - | - | - | - | - |
Affordability ratio | -0.6920 | 0.5989 | 1.0000 | - | - | - |
(P = 0.0266) | (P = 0.0673) | - | - | |||
GDP per capita | 0.9077 | -0.8810 | -0.7464 | 1.0000 | - | - |
(P = 0.0003) | (P = 0.0008) | (P = 0.0132) | - | - | - | |
% of public health expenditure in the total health expenditure | 0.3879 | -0.5338 | -0.1553 | 0.4907 | 1.0000 | - |
(P = 0.2680) | (P = 0.1120) | (P = 0.6683) | (P = 0.149) | - | - | |
% of general government expenditure in public health expenditure | 0.6661 | -0.4384 | -0.3741 | 0.4233 | 0.1547 | 1.0000 |
(P = 0.0713) | (P = 0.2772) | (P = 0.3612) | (P = 0.296) | (P = 0.7146) | - |
- Citation: Péntek M, Lakatos PL, Oorsprong T, Gulácsi L, Pavlova M, Groot W, Rencz F, Brodszky V, Baji P, Crohn’s Disease Research Group. Access to biologicals in Crohn’s disease in ten European countries. World J Gastroenterol 2017; 23(34): 6294-6305
- URL: https://www.wjgnet.com/1007-9327/full/v23/i34/6294.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i34.6294